A Phase 1/2 Double Blind, Randomized Controlled Study to Evaluate the Safety and Efficacy of RUT58-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics

Trial Profile

A Phase 1/2 Double Blind, Randomized Controlled Study to Evaluate the Safety and Efficacy of RUT58-60 Lavage Following Abdominal Surgery as an Adjunctive Therapy to Prophylactic Systemic Antibiotics

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 11 Aug 2015

At a glance

  • Drugs RUT 58 60 (Primary)
  • Indications Bacterial infections; Postoperative infections
  • Focus Adverse reactions
  • Sponsors Ruthigen
  • Most Recent Events

    • 06 Aug 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 04 Nov 2014 New source identified and integrated (ClinicalTirals.gov: US National Institutes of Health - NCT02280395).
    • 08 Oct 2014 Completion of enrolment of 20 patients in phase I is planned for the fourth quarter of 2014, and completion of enrolment of another 130 patients for phase II is planned by the end of the first quarter of 2015, according to a Ruthigen media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top